Monoclonal Antibody Therapy for Chronic lymphocytic leukemia (CLL)

Photos
Monoclonal Antibody Therapy for Chronic lymphocytic leukemia (CLL)
Featured
Detailed Information

Drug therapy using monoclonal antibodies can be an effective treatment. A monoclonal antibody is an immune protein made in a laboratory. It’s designed to target a specific molecule on the surface of Chronic lymphocytic leukemia (CLL) cells. The monoclonal antibody aims for the molecule and attaches itself to the cell, causing the cell to die. Monoclonal antibody therapies can cause side effects, but they’re generally milder than chemotherapy’s side effects. Because they’re designed to target and attack specific substances, they tend to leave normal cells unharmed.

Contact Us HBG MEDICAL ASSISTANCE
HBG Medical Assistance is working in association with all leading hospitals in India and provides the finest healthcare facilities. We bridge the gap between Indian Health Care and the rest of the world – Serving in Africa, the Middle East, CIS and Western World. HBG stands for each and every patient traveling through them – It guardians, It advocates and It ensures.




Send
Close Bitnami banner
Bitnami